0

Antibiotics Market by Application, Product, Drug Origin, Action Mechanism, and Geography - Forecast and Analysis 2021-2025

  • Published: Apr 2021
  • Pages: 120
  • SKU: IRTNTR41323
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The antibiotics market share is expected to increase by USD 4.44 billion from 2019 to 2024, and the market’s growth momentum will accelerate at a CAGR of 3.03%.

This antibiotics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antibiotics market segmentations by product (broad-spectrum antibiotics and narrow-spectrum antibiotics), application (natural, semisynthetic, and synthetic), and geography (APAC, North America, Europe, South America, and MEA). The antibiotics market report also offers information on several market vendors, including Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc., and Sanofi among others.

What will the Antibiotics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Global Antibiotics Market Size for the Forecast Period and Other Important Statistics

 

Antibiotics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The rising prevalence of infectious diseases is notably driving the global antibiotics market growth, although factors such as development of antibiotic-resistant strains may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the global antibiotics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antibiotics Market Driver

The rising prevalence of infectious diseases are one of the key factors driving the growth of the global antibiotics market. Demographic changes caused by increased globalization and urbanization are major factors leading to the global emergence of infectious diseases. Urbanization has led to the overcrowding of human inhabitants. High population densities in these areas favor the colonization of disease pathogens and their persistence in human populations. The expansion of human cities has negatively affected our ecosystems and natural landscapes. For instance, deforestation destroys the natural habitats of animals, which now localize near human habitats. Often these animals are vectors for pathogen transmission and, thus, their movement near human habitats also poses a risk of infection transmission to humans. The growing number of dams, poor living conditions, lack of sanitation, and inadequate waste management systems are some of the other factors that have increased the incidence and prevalence of diseases. In addition, the changes in environmental conditions and the growing trade and travel are contributing to the increase in the occurrence of infectious diseases among people.

Key Antibiotics Market Trend

The strategic alliances and mergers and acquisitions will fuel the global antibiotics market. The formation of strategic alliances, in terms of licensing and collaboration, helps in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertise from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company. Such agreements ensure the inflow of adequate funds from both the companies and help to reduce liability costs for individual companies in case of failures and attract more venture investments. M&A is usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Such a deal agreement allows the greater exposure of the drug in different regions. Also, smaller companies that are running short of revenue for the development of their drugs, often go for the M&A. Such agreements enable the complete development of the drugs and provide co-development and commercialization rights for the drugs in different regions.

Key Antibiotics Market Challenge

The development of antibiotic-resistant strains are a major challenge for the global antibiotics market growth. The development of multidrug-resistant microbes is one of the major threats to human health in the present day. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. Antibiotic resistance usually develops due to the irrational use of these drugs. The wrong prescription of the drugs by the physicians or the incorrect dosing or course taken by the individual due to lack of awareness along with the rampant use of these drugs in livestock, poultry, and other animal husbandry industries have led to the development of antibiotic-resistant strains of microorganism. This occurs because of the increased accumulation of drugs in the body. The commonly used antibiotic drugs thus become ineffective against the microbes, leading to aggravation of the disease in the body. The development of multidrug-resistant variants is acting as a challenge to the market growth, as the drugs available in the market do not show any efficacy in the treatment of these infections, thus decreasing the acceptance of these antibiotics.

This global antibiotics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2020-2024.

Parent Market Analysis

Technavio categorizes the global antibiotics market as a part of the pharmaceutical market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the global antibiotics market during the forecast period.

Who are the Major Antibiotics Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi

 

This statistical study of the global antibiotics market encompasses successful business strategies deployed by the key vendors. The global antibiotics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Abbott Laboratories - The company offers a range of antibiotic products such as cefditoren.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The global antibiotics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antibiotics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the global antibiotics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

 

Which are the Key Regions for Antibiotics Market?

For more insights on the market share of various regions Request for a FREE sample now!

49% of the market’s growth will originate from APAC during the forecast period. China, Japan, and India are the key markets for global antibiotics in APAC. Market growth in this region will be faster than the growth of the market in regions.

The rising prevalence of infectious diseases will facilitate the global antibiotics market growth in APAC over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 compelled governments of various countries to impose lockdowns in the region for several months. This affected the business and economic activities in countries like India, Pakistan, and Bangladesh. Although the pharmaceutical industry, inclusive of antibiotics, operated with limited capacity during this period under the safety guidelines laid down by the governments in this region, the imposition of lockdowns disrupted the supply chains of raw materials used for manufacturing antibiotics. This impacted the growth of the market to a certain extent. However, growing concern for health diseases among the people is expected to drive the growth of the market in the region during the forecast period.

What are the Revenue-generating Product Segments in the Antibiotics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The antibiotics market share growth by the broad-spectrum antibiotics segment will be significant during the forecast period. Broad-spectrum antibiotics are agents that are effective against a wide range of microorganisms, including Gram-positive and Gram-negative agents. These agents can be used in cases where bacteria do not respond to narrow-spectrum drugs, in cases of serious illness where the infecting agent is not identified, or in cases where multiple bacteria are resulting in the infection. However, the increased use of these agents leads to the development of resistance. Such factors will increase the market in focus during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the global antibiotics market size and actionable market insights on post COVID-19 impact on each segment.

 

 Antibiotics Market Scope

Report Coverage

Details

Page number

120

Base year

2019

Forecast period

2020-2024

Growth momentum & CAGR

Accelerate at a CAGR of 3.03%

Market growth 2020-2024

$ 4.44 billion

Market structure

Fragmented

YoY growth (%)

2.17

Regional analysis

APAC, North America, Europe, South America, APAC, North America, Europe, South America, APAC, North America, Europe, South America, APAC, North America, Europe, and South America

Performing market contribution

APAC at 49%

Key consumer countries

US, China, Japan, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc., and Sanofi

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Global Antibiotics Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive global antibiotics market growth during the next five years
  • Precise estimation of the global antibiotics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the global antibiotics industry across APAC, North America, Europe, South America, APAC, North America, Europe, South America, APAC, North America, Europe, South America, APAC, North America, Europe, and South America
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of global antibiotics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Broad-spectrum antibiotics - Market size and forecast 2020-2025
    • Narrow-spectrum antibiotics - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • Asia - Market size and forecast 2020-2025
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Abbott Laboratories
      • AbbVie Inc.
      • AstraZeneca Plc
      • Bayer AG
      • F. Hoffmann-La Roche Ltd.
      • Johnson & Johnson
      • Mayne Pharma Group Ltd.
      • Merck KGaA
      • Pfizer Inc.
      • Sanofi SA

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The antibiotics market growth will increase by $4.44 billion during 2020-2024.
      The antibiotics market is expected to grow at a CAGR of 3.03% during 2020-2024.
      Technavio has segmented the antibiotics market by product (Broad-spectrum antibiotics and Narrow-spectrum antibiotics) ,other 1 (Natural, Semisynthetic, and Synthetic) , and geographic (APAC, North America, Europe, South America, and APAC).
      Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc., Sanofi are a few of the key vendors in the antibiotics market.
      APAC will register the highest growth rate of 48.96% among the other regions. Therefore, the antibiotics market in APAC is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the antibiotics market growth are:
      • Rising prevalence of infectious diseases
      • Strategic alliances and mergers and acquisitions (M&A )
      The antibiotics market vendors should focus on grabbing business opportunities from the broad-spectrum antibiotics segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>